Metformin Hydrochloride
- Product NDC
- 51655-853
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metformin Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Northwind Health Company, LLC
- Application
- ANDA206145
- Marketing category
- ANDA
- Substance
- METFORMIN HYDROCHLORIDE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 51655-853-25 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-853-25) | 2022-10-07 | | No | Historical |
| 51655-853-26 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-853-26) | 2023-10-03 | | No | Historical |
| 51655-853-52 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-853-52) | 2022-12-19 | | No | Historical |
| 51655-853-82 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-853-82) | 2022-10-25 | | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Metformin Hydrochloride | Northwind Health Company, LLC | 2026-01-01 | HUMAN PRESCRIPTION DRUG LABEL | 5 |